Home › NDC Lookup › RxCUI directory › RxCUI 403799

84 HR oxybutynin 0.162 MG/HR Transdermal System — RxCUI 403799

RxNorm drug concept · Semantic clinical drug
RxCUI 403799 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI403799
Official name84 HR oxybutynin 0.162 MG/HR Transdermal System
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asoxybutynin 0.162 MG/HR 84 HR Transdermal Patch; oxyBUTYnin 3.9 MG/Day Twice Weekly Transdermal System; oxybutynin 3.9 MG/Day Twice Weekly Transdermal Patch
FDA products mapped2
Package NDCs mapped3
Reported Medicaid activity (SDUD)802 prescriptions · 10 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Oxybutynin Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • The patch works by calming the bladder muscle so it doesn't squeeze unexpectedly. That helps reduce the sudden urge to rush to the bathroom, how often you need to go, and accidenta...
  • What exactly does this patch do — and how long before I notice a difference?
  • You can wear the patch on your abdomen, hip, or buttocks — whichever is most comfortable and easiest to keep covered by clothing. Apply it to clean, dry skin with no lotions, oils,...
  • Where do I put the patch, and how often do I change it?
📖 Read our full Oxybutynin Transdermal Patch guide →

🕸️ Concept Web — How 84 HR oxybutynin 0.162 MG/HR Transdermal System Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 84 HR oxybutynin 0.162 MG/HR Transdermal System RxCUI 403799

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Oxybutynin 32675
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Oxytrol 356886
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Oxybutynin Transdermal System 1805970
    • Oxybutynin Topical Product 1160157
    • Oxybutynin Transdermal Product 1295592
    • Oxybutynin Transdermal System [Oxytrol] 1805972
    • Oxytrol Topical Product 1177040
    • Oxytrol Transdermal Product 1296605
    • Transdermal System 316987
    • Topical Product 1151122
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Oxybutynin 0.162 MG/HR SCDC · 406138
  • Oxybutynin Transdermal System SCDF · 1805970
  • Oxybutynin Topical Product SCDG · 1160157
  • Oxybutynin Transdermal Product SCDG · 1295592

Brand-Name Concepts

📦 FDA Products & Package NDCs

2 products · 3 package NDCs
3 package NDCs map to RxCUI 403799 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00023-6153-08 8 POUCH in 1 BOX (0023-6153-08) / 1 PATCH in 1 POUCH / 4 d... OXYTROL Allergan, Inc. 2003-02-26
00023-9637-04 16 PATCH in 1 CARTON (0023-9637-04) / 4 d in 1 PATCH Oxytrol for Women Allergan, Inc. 2016-01-01
00023-9637-08 32 PATCH in 1 CARTON (0023-9637-08) / 4 d in 1 PATCH Oxytrol for Women Allergan, Inc. 2019-10-01
Observed labelers: Allergan, Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$2.7291
Range $2.7291–$81.5178 · middle 50% $2.7291–$42.1235 · 3 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.